A yau, Kotun Shari'a ta Turai ta yanke hukuncin cewa Hukumar Tarayyar Turai ta sake amincewa dacypermethrina shekarar 2021 ba bisa ƙa'ida ba ne. Hukuncin ya bayyana cewa takardun sake amincewa da su sun ƙunshi manyan kurakurai, matakan rage haɗarin kwari waɗanda aka gina su a kai ba su da hujjar kimiyya da kuma yuwuwar amfani, kuma ba a tantance gubar da ta daɗe tana faruwa a cikin samfurin guda ɗaya da ke ɗauke da cypermethrin ba. Kotun ta tabbatar da cewa dole ne a yanke shawarar Hukumar Turai bisa ga shaidar kimiyya kuma a tabbatar da isasshen hujja.
Wannan shi ne karo na farko da wata ƙungiyar farar hula ta shigar da ƙara a Kotun Shari'a ta Turai (ECJ) game da amincewa da magungunan kashe kwari na EU. Wannan ya yiwu ne ta hanyar gyare-gyaren da aka yi a Dokar Aarhus ta 2021, wanda ya bai wa ƙungiyoyin sa kai damar shari'a don ƙalubalantar amincewa da magungunan kashe kwari a matakin EU. A shekarar 2024, Babban Kotun Tarayyar Turai ta yi watsi da wata ƙara da ke ƙalubalantar sake amincewa da maganin cypermethrin[1], kuma daga baya PAN Turai ta ɗaukaka ƙara zuwa ECJ.[2][3] A watan Yunin 2025, Babban Mai Gabatar da Kara na ECJ ya bayar da ra'ayi[4] wanda ke goyon bayan yawancin hujjojin PAN Turai. A hukuncin da aka yanke a yau, Kotun ta amince da wasu ayyuka da ba bisa ƙa'ida ba, amma masu muni da kuma masu sake faruwa da Hukumar Turai.
"Kotun Shari'a ta Turai ta sake nanata cewa dole ne a yanke hukunci kan magungunan kashe kwari bisa ga shaidar kimiyya kuma a sami isassun dalilai, daidai da hukunce-hukuncen da aka yanke a baya; duk da haka, wannan shari'ar ba ta cika waɗannan sharuɗɗan ba," in ji Martin Demeeneer, Babban Daraktan PAN Turai. "Dokokin EU ba su da amfani: abin takaici ne cewa Hukumar Turai wani lokacin tana sake tabbatar da abubuwan da ba su cika ƙa'idodin tsaro ba a ƙarƙashin matsin lamba daga ƙasashen membobinta (kamar yadda yake a yanayin cypermethrin), kuma wannan yana faruwa akai-akai."
Hukuncin ya jaddada cewa Hukumar Tarayyar Turai ba za ta iya yin watsi da binciken kimiyya na Hukumar Kula da Abinci ta Turai (EFSA) ba tare da hujjoji masu ƙarfi da suka dogara da shaida ba.
"Hukumar Tsaron Abinci ta Turai (EFSA) ta bayyana karara cewa ba za a iya tantance amfani da cypermethrin lafiya a yanayin duniya na ainihi ba. Duk da haka, Hukumar Turai ta saba wa wannan ta hanyar haɓaka matakan rage haɗari marasa tabbas, kamar rage feshi da kashi 99% ba tare da gaskiya ba, da kuma iƙirarin cewa waɗannan matakan za su sa maganin ya zama lafiya don amfani. Abin takaici, wannan ba lamari ne da aka keɓe ba, amma aiki ne da ya yaɗu," in ji Salomé Reunell, Jami'in Manufofi a PAN Europe.
Farfesa Antoine Bayocques, Mai Ba da Shawara Kan Shari'a ga Ƙungiyar Kare Shuke-shuke ta Turai (PAN Europe), ya ce: "Wannan shawarar ta zo ne a matsayin ƙarfafawa bayan yanke shawara mai ban takaici ta Babban Kotun Tarayyar Turai. Har ma ina ganin hakan a matsayin wani abin bege a lokacin da dokokin muhalli suka tabarbare sosai. Kotun da Babban Lauya sun amince cewa, a tsakanin sauran abubuwa, ya kamata a yi la'akari da waɗannan batutuwa: (1) Hukumar Turai dole ne ta bayar da cikakken bayani game da dalilin da ya sa ta amince da sabunta rajistar wani abu mai aiki duk da cewa Hukumar Tsaron Abinci ta Turai (EFSA) ta gano 'mahimman fannoni da ke damun ta'. Misali, Hukumar Turai ba za ta iya sake amincewa da wani abu mai aiki ba bisa dalilin cewa za a iya 'rage' tasirinsa ga namun daji (ƙudan zuma, kwaɗi, da sauransu) ta hanyar matakan da ba a tabbatar da yiwuwa ba; (2) Dole ne a yi nazari sosai kan gubar da ke tattare da kayan kariya na tsire-tsire daban-daban (gami da, amma ba'a iyakance ga, abubuwa masu aiki ba) na dogon lokaci, gami da 'tasirinsu gauraye'. Waɗannan batutuwa biyu a bayyane suke, amma an rasa su lokacin da aka tsawaita rajistar cypermethrin."
Wannan shawara ta soke shawarar da Hukumar Tarayyar Turai ta yanke na kin amincewa da bukatar PAN Europe na yin bita a cikin gida, wanda ya nemi a soke shawarar Hukumar na tsawaita izinin Tarayyar Turai na cypermethrin. Dole ne Hukumar Tarayyar Turai ta aiwatar da hukuncin yanzu kuma ta sake duba shawarar da ta yanke. Wannan zai haifar da soke izinin cypermethrin.
Cypermethrin wani maganin kashe kwari ne na roba wanda ke da guba sosai ga ƙudan zuma da halittun ruwa kuma ana zargin yana kawo cikas ga tsarin endocrine na ɗan adam. Duk da alamun gargaɗi bayyanannu ("wuraren da ke da matukar damuwa") da kuma cikakkun takardu, Hukumar Tarayyar Turai da ƙasashen Membobi sun sake amincewa da amfani da shi a shekarar 2021. PAN Turai ta shigar da ƙara, tana mai jayayya cewa Hukumar Tarayyar Turai ta yi watsi da dokar Tarayyar Turai, kimanta kimiyya ta Hukumar Tsaron Abinci ta Turai (EFSA), da kuma ƙa'idar kariya.
[1] A ranar 21 ga Fabrairu 2024, Babban Kotun Tarayyar Turai ta yanke hukunci a Shari'ar da aka yi wa lamba T-536/22, PAN Europe da Hukumar Tarayyar Turai.
[2] A ranar 29 ga Afrilu 2024, PAN Europe ta ɗaukaka ƙara kan hukuncin Kotun Tarayyar Turai (Ɗaki na Huɗu) a shari'ar T-536/22, wadda aka yanke a ranar 21 ga Fabrairu 2024.
[3] Ƙungiyar Tarayyar Turai ta ɗaukaka ƙara a kan hukuncin da Kotun Tarayyar Turai ta yanke game da sake amincewa da EU na cypermethrin mai rushewar endocrine.
© Cibiyar Ayyukan Kwari ta Turai (PAN Turai), Adireshi: Rue de la Pacification 67, 1000 Brussels, Belgium, Tel.: +32 2 318 62 55
Ƙungiyar Ayyukan Kashe Kwayoyin Cuka (PAN Europe) ta yi godiya ga tallafin da Tarayyar Turai, Hukumar Turai, Babban Darakta kan Muhalli, da shirin LIFE suka bayar. Marubutan ne kawai ke da alhakin wannan littafin, kuma ƙungiyoyin da ke ba da tallafi ba sa ɗaukar alhakin duk wani amfani da za a iya yi wa bayanan da ke cikinsa.
Lokacin Saƙo: Maris-09-2026